দেশ: মাল্যাশিয়া
ভাষা: ইংরেজি
সূত্র: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
DESONIDE
HOE PHARMACEUTICALS SDN. BHD.
DESONIDE
30gm mcg/mL; 30 ml mL
HOE PHARMACEUTICALS SDN. BHD.
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ 1 EZENIDE LOTION Desonide (0.05% w/w) _ _ WHAT IS IN THIS LEAFLET 1. What Ezenide Lotion is used for 2. How Ezenide Lotion works 3. Before you use Ezenide Lotion 4. How to use Ezenide Lotion 5. While you are using Ezenide Lotion 6. Side effects 7. Storage and disposal of Ezenide Lotion 8. Product description 9. Manufacturer and Product Registration Holder 10. Date of revision This leaflet answers some common questions about Ezenide Lotion. It does not contain all the available information. It does not take the place of talking to your pharmacist or doctor. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR PHARMACIST OR DOCTOR. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT EZENIDE LOTION IS USED FOR Ezenide Lotion is used to suppress skin disease in which inflammation and itching are the prominent features. These skin problems do respond to corticosteroids. HOW EZENIDE LOTION WORKS Ezenide Lotion contains a medicine called desonide. It belongs to a group of medicines called steroids. It is a topically active, nonfluorinated corticosteroid which has anti- inflammatory, anti-itching and blood vessels constricting actions. BEFORE YOU USE EZENIDE LOTION _ _ _ _ _- When you must not use it _ DO NOT USE EZENIDE LOTION: If you are allergic (hypersensitive) to desonide, other corticosteroids, or any components in the base of Ezenide Lotion. _- Before you start to use it _ Tell your pharmacist or doctor: If you are applying the lotion under an airtight dressing, including a child’s nappy. These dressings make it easier for the active ingredient to pass through the skin. It is possible to accidentally end up using too much lotion. If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before using this medicine. PREGNANCY AND BREAST FEEDING: Ask your doctor or pharmacist for advice before taking this medicine if you are pregnant or breast-feeding. The safety of using Ezenide Lotion during pregnancy সম্পূর্ণ নথি পড়ুন
EZENIDE LOTION 0.05% W/W Date edited : 20-11-2020 Paper : white simili 70gsm NAME AND STRENGTH OF ACTIVE SUBSTANCE: Desonide 0.05% w/w. PRODUCT DESCRIPTION: Off-white opaque viscous lotion with characteristic odour. Other ingredients are Disodium Edetate, Citric Acid Anhydrous, Xanthan Gum, Sodium Benzoate, Disodium Hydrogen Phosphate Dihydrate, Saccharide lsomerate, Polysorbate 60, Cetostearyl Alcohol, Sorbitan Monostearate, Macrogol 400, Squalane and Purified Water. PHARMACODYNAMICS: Desonide is a topically active, nonfluorinated corticosteroid which has anti-inflammatory, antipruritic and vasoconstrictive actions. PHARMACOKINETICS: Corticosteroids are extensively bound to plasma proteins. Only unbound corticosteroids have pharmacological effects or are metabolised. They are metabolised mainly in the liver and also in the kidney, and are excreted in the urine. INDICATIONS: For the relief of inflammatory and pruritic manifestation of corticosteroid- responsive dermatoses. CONTRAINDICATIONS: Hypersensitivity to Desonide, other corticosteroids, or any component in the base. ADVERSE EFFECTS: Reported local adverse reactions are burning sensation, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. PRECAUTIONS/WARNINGS: Discontinue use if irritation, sensitivity or other reaction develops and institute appropriate treatment. Corticosteroid applied to the skin can be absorbed in sufficient amount to produce systemic effects such as hypothalamic-pituitary-adrenal axis suppression, manifestation of Cushing's syndrome, hyperglycaemia and glucosuria. Thus suitable precautions should be taken during prolonged treatment, when treating extensive body surface areas, when using the occlusive technique and when treating children (because of a larger skin surface area to bodyweight ratio). The safety of using topical corticosteroids during pregnancy and lactation has not been established. ROUTE OF ADMIN সম্পূর্ণ নথি পড়ুন